Washington [US], September 12 Morning India: There may be a greater risk of developing anxiety for patients suffering from autoimmune inflammation of their thyroid, suggest the findings of a new study.
The study was presented at e-ECE 2020.
The study found that people with anxiety may also have inflammation in their thyroid gland that can be reduced by taking the non-steroidal anti-inflammatory, ibuprofen. These findings suggest that thyroid function may play an important role in the development of anxiety disorders and that thyroid inflammation should be investigated as an underlying factor in psychiatric disorders, such as anxiety.
At present, up to 35 per cent of the young population (25-60 years) in developed countries have an anxiety disorder. Anxiety can have a severe impact on people’s quality of life and ability to work and socialise, and anti-anxiety medication does not always have a lasting effect. Current examinations for anxiety disorders usually focus on the dysfunction of the nervous system and do not take into account the role of the endocrine system.